Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hannah Daniel

Reporter

Hannah joined Medtech Insight from HBW Insight in August 2022 and reports on cybersecurity, patent law and other facets of medical device regulation. Hannah is passionate about the intersection of science and communication and holds a bachelor’s degree in biology from Carnegie Mellon University.

Latest From Hannah Daniel

Easier Access To Funding: FCC Rural Health Care Program Seeks Comments On New Actions

The Federal Communications Commission recently approved four proposals and seeks comments on four others to increase telemedicine access for rural communities.

Policy Telehealth

Sotera Health Class Action Suit: Executives ‘Misled Investors’ During Public Offerings

Following Sterigenic’s $408m EtO settlement, a securities class action lawsuit has been filed against its parent company Sotera Health Company.

Legal Issues Regulation

Updated GUDID Data Shows Product Details For 4M Devices

The FDA recently released an updated set of data drawn from devices in the GUDID database, which now includes almost 4 million products.

FDA Regulation

News We're Watching – 27 January

This feature compiles news briefs on a range of US regulatory and legal happenings. This week: Medtronic seeks HeartWare batteries; companies sign health equity pledge; insulin dosing app cleared; recall on field decontamination kits; and the renewal of an FDA panel. 

Regulation FDA

Expert: FTC Clinical Data Requirements A Likely Challenge For Medtech Companies

Medtech Insight spoke to Sidley Austin LLP partner Jeff Senger about the challenges companies may face navigating the FTC’s updated health products guidance.

Advertising, Marketing & Sales Clinical Trials

Researchers Suggest More Care In Using Abbott’s MitraClip

New data aggregated from over 5,000 reported adverse events suggests that patients should be aware of risks using MitraClip for TEER and operators should take more caution in handling the device.

Regulation Commercial
See All
UsernamePublicRestriction

Register